Amarin Corp Plc (AMRN)

[ziploc_1]

Kowa did not agree to market Vascepa for the payments they might receive from Amarin. They did it to "test the waters" especially as Vascepa relates to Pitivastin and to get to know Amarin and its management. They gave Amarin a rather generous deal to get in on the ground floor when R-IT gets to be successful. We don't know whether they have a clause, which gives them the right of first refusal in case of a bid for the company, or some other rights, but I wouldn't be surprised.